GALT logo

Galectin Therapeutics (GALT) Company Overview

Profile

Full Name:

Galectin Therapeutics Inc.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

September 4, 2002

Indexes:

Not included

Description:

Galectin Therapeutics (GALT) is a biotechnology company focused on developing treatments for serious diseases, particularly liver and cancer-related conditions. They specialize in galectin-based therapies, aiming to improve patient outcomes through innovative drug development and research.

Events Calendar

Earnings

Next earnings date:

Mar 28, 2025

Recent quarterly earnings:

Nov 14, 2024

Recent annual earnings:

Mar 29, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

Mar 23, 2012

Analyst ratings

Recent major analysts updates

Dec 27, 24 HC Wainwright & Co.
Neutral
Nov 15, 24 HC Wainwright & Co.
Buy
Aug 16, 24 HC Wainwright & Co.
Buy
Apr 9, 24 HC Wainwright & Co.
Buy
Apr 1, 24 HC Wainwright & Co.
Buy
Aug 15, 23 HC Wainwright & Co.
Buy
May 17, 23 HC Wainwright & Co.
Buy
Mar 3, 23 HC Wainwright & Co.
Buy
May 17, 22 HC Wainwright & Co.
Buy
Apr 16, 21 HC Wainwright & Co.
Buy

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for Galectin Therapeutics?
  • Does Galectin Therapeutics pay dividends?
  • What sector is Galectin Therapeutics in?
  • What industry is Galectin Therapeutics in?
  • What country is Galectin Therapeutics based in?
  • When did Galectin Therapeutics go public?
  • Is Galectin Therapeutics in the S&P 500?
  • Is Galectin Therapeutics in the NASDAQ 100?
  • Is Galectin Therapeutics in the Dow Jones?
  • When was Galectin Therapeutics's last earnings report?
  • When does Galectin Therapeutics report earnings?
  • Should I buy Galectin Therapeutics stock now?

What is the ticker symbol for Galectin Therapeutics?

The ticker symbol for Galectin Therapeutics is NASDAQ:GALT

Does Galectin Therapeutics pay dividends?

No, Galectin Therapeutics does not pay dividends

What sector is Galectin Therapeutics in?

Galectin Therapeutics is in the Healthcare sector

What industry is Galectin Therapeutics in?

Galectin Therapeutics is in the Biotechnology industry

What country is Galectin Therapeutics based in?

Galectin Therapeutics is headquartered in United States

When did Galectin Therapeutics go public?

Galectin Therapeutics's initial public offering (IPO) was on September 4, 2002

Is Galectin Therapeutics in the S&P 500?

No, Galectin Therapeutics is not included in the S&P 500 index

Is Galectin Therapeutics in the NASDAQ 100?

No, Galectin Therapeutics is not included in the NASDAQ 100 index

Is Galectin Therapeutics in the Dow Jones?

No, Galectin Therapeutics is not included in the Dow Jones index

When was Galectin Therapeutics's last earnings report?

Galectin Therapeutics's most recent earnings report was on Nov 14, 2024

When does Galectin Therapeutics report earnings?

The next expected earnings date for Galectin Therapeutics is Mar 28, 2025

Should I buy Galectin Therapeutics stock now?

As of today, analysts generally recommend a 'Hold' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions